Cameron John Reynolds - Dec 9, 2024 Form 4 Insider Report for VOLITIONRX LTD (VNRX)

Role
President and CEO, Director
Signature
/s/ Cameron John Reynolds
Stock symbol
VNRX
Transactions as of
Dec 9, 2024
Transactions value $
$80,000
Form type
4
Date filed
12/10/2024, 04:01 PM
Previous filing
Sep 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VNRX Common Stock Purchase $80K +140K +7.07% $0.57 2.12M Dec 9, 2024 Direct F1
holding VNRX Common Stock 1.01M Dec 9, 2024 By Concord International, Inc. F2
holding VNRX Common Stock 34.1K Dec 9, 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired at the offering price in the registered direct offering of Common Stock by VolitionRx.
F2 The shares of common stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of common stock held by Concord International, Inc